Effect of beclomethasone dipropionate and dexamethasone isonicotinate on lung function, bronchoalveolar lavage fluid cytology, and transcription factor expression in airways of horses with recurrent airway obstruction

Journal of Veterinary Internal Medicine

Volumn 20, Issue 2, 2006, Pages 399-406

  Couëtil, Laurent L ^a,b,c   Art, Tatiana ^a   De Moffarts, Brieuc ^a   Becker, Martine ^a   Mélotte, Dorothée ^a   Jaspar, Fabrice ^a   Bureau, Fabrice ^a   Lekeux, Pierre ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b PURDUE UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

Activator protein 1; Glucocorticoids; Inflammation; Lung function; Nuclear factor B

Indexed keywords

ANTIINFLAMMATORY AGENT; BECLOMETASONE; DEXAMETHASONE ISONICOTINATE; TRANSCRIPTION FACTOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYTOLOGY; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; HORSE; HORSE DISEASE; LUNG; LUNG LAVAGE; MALE; METABOLISM; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BECLOMETHASONE; BRONCHOALVEOLAR LAVAGE FLUID; CROSS-OVER STUDIES; DEXAMETHASONE ISONICOTINATE; FEMALE; GENE EXPRESSION REGULATION; HORSE DISEASES; HORSES; LUNG; LUNG DISEASES, OBSTRUCTIVE; MALE; RESPIRATORY THERAPY; TRANSCRIPTION FACTORS;

EQUIDAE; EQUUS CABALLUS;

EID: 33645582276     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2006)20[399:EOBDAD]2.0.CO;2     Document Type: Article

References (45)

1. Robinson NE, Derksen FJ, Olszewski MA, Buechner-Maxwell VA. The pathogenesis of chronic obstructive pulmonary disease of horses. Br Vet J 1995;152:283-306.
2. Derksen FJ, Robinson NE, Armstrong PJ, Stick JA, Slocombe RF. Airway reactivity in ponies with recurrent airway obstruction (heaves). J Appl Physiol 1985;58:598-604.
3. Park H, Jung K, Hwang S, Nahm D, Yim H. Neutrophil infiltration and release of IL-8 in airway mucosa from subjects with grain dust-induced occupational asthma. Clin Exp Allergy 1998;28:724-730.
4. Louis R, Lau L, Bron A, Roldaan A, Radermecker M, Djukanovic R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000;161:9-16.
5. Barnes P, Adcock I. Transcription factors and asthma. Eur Respir J 1998;12:221-234.
6. Bureau F, Bonizzi G, Kirschvink N, et al. Correlation between nuclear factor-kappaB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma. Am J Respir Crit Care Med 2000;161:1314-1321.
7. Rush B, Raub E, Rhoads W, et al. Pulmonary function in horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. Am J Vet Res 1998;59:1039-1043.
8. Picandet V, Leguillette R, Lavoie J. Comparison of efficacy and tolerability of isoflupredone and dexamethasone in the treatment of horses affected with recurrent airway obstruction ("heaves"). Equine Vet J 2003;35:419-424.
9. Lapointe JM, Lavoie JP, Vrins AA. Effects of triamcinolone acetonide on pulmonary function and bronchoalveolar lavage cytologic features in horses with chronic obstructive pulmonary disease. Am J Vet Res 1993;54:1310-1316.
10. Derksen FJ. Chronic obstructive pulmonary disease. In: Beech J, ed. Equine Respiratory Disorders. Philadelphia, PA: Lea and Febiger; 1991:223-235.
11. Robinson NE, Jackson C, Jefcoat A, et al. Efficacy of three corticosteroids for the treatment of heaves. Equine Vet J 2002;34:17-22.
12. Lekeux P, Duvivier DH. Aerosol Therapy in the Equine Species. 561-563. 1996. Lakewood, CO, Proceedings ACVIM.
13. Ammann VJ, Vrins AA, Lavoie JP. Effects of inhaled beclomethasone dipropionate on respiratory function in horses with chronic obstructive pulmonary disease (COPD). Equine Vet J 1998;30:152-157.
14. Rush BR, Raub ES, Rhoads WS, et al. Pulmonary function in horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. Am J Vet Res 1998;59:1039-1043.
15. Rush B, Raub E, Thomsen M, et al. Pulmonary function and adrenal gland suppression with incremental doses of aerosolized beclomethasone dipropionate in horses with recurrent airway obstruction. J Am Vet Med Assoc 2000;217:359-364.
16. Art T, Serteyn D, Lekeux P. Effect of exercise on the partitioning of equine respiratory resistance. Equine Vet J 1988;20:268-273.
17. Derksen F, Olszewski M, Robinson N, et al. Aerosolized albuterol sulfate used as a bronchodilator in horses with recurrent airway obstruction. Am J Vet Res 1999;60:689-693.
18. Robinson NE, Olszewski MA, Boehler D, et al. Relationship between clinical signs and lung function in horses with recurrent airway obstruction (heaves) during a bronchodilator trial. Equine Vet J 2000;32:393-400.
19. Toutain PL, Brandon RA, de Pomyers H. Dexamethasone and prednisolone in the horse: Pharmacokinetics and action on the adrenal gland. Am J Vet Res 1984;45:1750-1756.
20. Lavoie JP, Leguillette R, Pasloske K, et al. Comparison of effects of dexamethasone and the leukotriene D4 receptor antagonist L-708,738 on lung function and airway cytologic findings in horses with recurrent airway obstruction. Am J Vet Res 2002;63:579-585.
21. Picandet V, Leguillette R, Lavoie JP. Comparison of efficacy and tolerability of isoflupredone and dexamethasone in the treatment of horses affected with recurrent airway obstruction ('heaves'). Equine Vet J 2003;35:419-424.
22. Friedrich A, Schulz R, Meyer HHD. Use of enzyme-immunoassay and reverse-phase high-performance liquid-chromatography to detect and confirm identity of dexamethasone in equine blood. Am J Vet Res 1992;53:2213-2220.
23. Fairbairn S, Page C, Lees P, Cunningham F. Early neutrophil but not eosinophil or platelet recruitment to the lungs of allergic horses following antigen exposure. Clin Exp Allergy 1993;23:821-828.
24. Grunig G, Hermann M, Howald B, Winder C, Vonfellenberg R. Partial divergence between airway inflammation and clinical signs in equine chronic pulmonary disease. Equine Vet J 1989;21:145-148.
25. Rush BR, Flaminio MJ, Matson CJ, Hakala JE, Shuman W. Cytologic evaluation of bronchoalveolar lavage fluid from horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. Am J Vet Res 1998;59:1033-1038.
26. Rush B, Flaminio J, Matson C, Hakala J, Shuman W. Cytologic evaluation of bronchoalveolar lavage fluid from horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. Am J Vet Res 1998;59:1033-1038.
27. Lukacs N. Role of chemokines in the pathogenesis of asthma. Nat Rev Immunol 2001;1:108-116.
28. Turlej RK, Fievez L, Sandersen CF, et al. Enhanced survival of lung granulocytes in an animal model of asthma: Evidence for a role of GM-CSF activated STAT5 signalling pathway. Thorax 2001;56:696-702.
29. Manning A, Bell F, Rosenbloom C, et al. NF-κB is activated during acute inflammation in vivo in association with elevated endothelial cell adhesion molecule gene expression and leukocyte recruitment. J Inflamm 1995;45:283-296.
30. Nguyen C, Teo J-L, Matsuda A, et al. Chemogenomic identification of Ref-1/AP-1 as a therapeutic target for asthma. Proc Natl Acad Sci 2003;100:1169-1173.
31. Hartenstein B, Teurich S, Hess J, et al. Th2 cell-specific cytokine expression and allergen-induced airway inflammation depend on JunB. EMBO J 2002;21:6321-6329.
32. Yang L, Cohn L, Zhang D-H, et al. Essential role of nuclear factor kB in the induction of eosinophilia in allergic airway inflammation. J Exp Med 1998;188:1739-1750.
33. Donovan C, Mark D, He H, et al. NF-kB/Rel transcription factors: c-Rel promotes airway hyperresponsiveness and allergic pulmonary inflammation. J Immunol 1999;163:6827-6833.
34. Hart L, Krishman V, Adcock I, Barnes P, Chung K. Activation and localization of transcription factor, nuclear factor-kappa B, in asthma. Am J Respir Crit Care Med 1998;158:1585-1592.
35. Demoly P, Basset-Seguin N, Chanez P, et al. c-fos proto-oncogene expression in bronchial biopsies of asthmatics. Am J Respir Cell Mol Biol 1992;7:128-133.
36. Sandersen C, Bureau F, Turlej R, et al. p65 Homodimer activity in distal airway cells determines lung dysfunction in equine heaves. Vet Immunol Immunopathol 2001;80:315-326.
37. Barnes P. New directions in allergic diseases: Mechanism-based anti-inflammatory therapies. J Allergy Clin Immunol 2000;106:5-16.
38. Wilson S, Wallin A, Della-Cioppa G, Sandstrom T, Holgate S. Effects of budesonide and formoterol on NF-kB, adhesion molecules, and cytokines in asthma. Am J Respir Crit Care Med 2001;164:1047-1052.
39. Hancox R, Stevens D, Adcock I, Barnes P, Taylor D. Effects of inhaled β agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma. Thorax 1999;54:488-492.
40. Demoly P, Chanez P, Pujol J, et al. Fos immunoreactivity assessment on human normal and pathological bronchial biopsies. Respir Med 1995;89:329-335.
41. Hart L, Lim S, Adcock I, Barnes P, Chung K. Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor-kB in asthma. Am J Respir Crit Care Med 2000;161:224-231.
42. Kracht M, Saklatvala J. Transcriptional and post-transcriptional control of gene expression in inflammation. Cytokine 2002;20:91-106.
43. Barnes P, Adcock I. How do corticosteroids work in asthma? Ann Intern Med 2003;139:359-370.
44. Ito K, Barnes P, Adcock I. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1 beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 2000;20:6891-6903.
45. Bureau F, Delhalle S, Bonizzi G, et al. Mechanisms of persistent NF-kappa B activity in the bronchi of an animal model of asthma. J Immunol 2000;165:5822-5830.